<DOC>
	<DOCNO>NCT02112305</DOCNO>
	<brief_summary>The purpose study determine whether nebulized magnesium sulphate effective treatment acute severe asthma comparison intravenous magnesium sulphate</brief_summary>
	<brief_title>Compare Efficacy Nebulized Intravenous Magnesium Sulphate Thai Children</brief_title>
	<detailed_description>Intervention : At randomization eligible patient allocate receive 2.5ml isotonic magnesium sulphate ( 150 mg,245 mmol/L ) three occasional 20 minute interval standard treatment 50 mg/kg intravenous magnesium sulphate . The asthma severity score record 0,20,40,60,120,180,240 minute post randomization . Adverse event assess assessment point . Patients follow discharge hospital collect secondary outcome data .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Status Asthmaticus</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Children age 215 year present severe asthma persistent wheeze without respond conventional therapy chronic lung disease history adverse reaction form magnesium sulphate life threaten condition</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Magnesium sulphate nebulized</keyword>
</DOC>